Related Experiment Videos
A new oral contraceptive based on the normophasic method
Arzneimittel-Forschung
|January 1, 1976
Summary
Fisioquens, a normophasic oral contraceptive, demonstrated 100% efficacy in preventing pregnancy over 554 cycles. This oral contraceptive showed good tolerance and cycle control with minimal side-effects in 62 women.
Area of Science:
- Reproductive Health
- Pharmacology
Background:
- Oral contraceptives are widely used for family planning.
- Normophasic oral contraceptives offer a specific hormonal regimen.
- Assessing the efficacy and tolerability of oral contraceptives is crucial.
Purpose of the Study:
- To evaluate the contraceptive efficacy of Fisioquens.
- To assess the tolerability and cycle control of Fisioquens.
- To document side-effects associated with Fisioquens use.
Main Methods:
- A study involving 62 women treated for 554 cycles.
- Fisioquens regimen: 7 tablets of 0.05 mg ethinylestradiol, followed by 15 tablets of 0.05 mg ethinylestradiol and 1 mg lynestrenol.
- Monitoring for pregnancies, side-effects, and cycle control.
Main Results:
- No pregnancies were reported during the study period.
- Good tolerance and cycle control were observed in most participants.
- Sporadic irregular bleeding occurred, and other side-effects diminished over time.
Conclusions:
- Fisioquens is a reliable contraceptive method.
- The oral contraceptive exhibits a favorable side-effect profile.
- Fisioquens demonstrates good tolerability and cycle regulation.
Keywords:
BehaviorBleedingCentral Nervous System EffectsClinical ResearchContraceptionContraceptive AgentsContraceptive Agents, EstrogenContraceptive Agents, FemaleContraceptive Agents, ProgestinContraceptive EffectivenessDecreased LibidoDiseasesEthinyl EstradiolFamily PlanningLynestrenolMetrorrhagiaOral ContraceptivesOral Contraceptives, CombinedOral Contraceptives, PhasicResearch MethodologySex BehaviorSigns And SymptomsUse-effectiveness